Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 6
1986 1
1988 3
1989 3
1990 3
1991 1
1992 3
1993 3
1994 1
1995 4
1996 2
1997 3
1998 4
1999 1
2000 5
2001 3
2002 4
2003 4
2004 6
2005 5
2006 6
2007 9
2008 6
2009 4
2010 4
2011 8
2012 5
2013 2
2014 5
2015 2
2016 2
2017 4
2018 4
2019 3
2020 2
2021 5
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: zernig g. Pharmacopsychiatry. 2018 Jan;51(1-02):9-62. doi: 10.1055/s-0043-116492. Epub 2017 Sep 14. Pharmacopsychiatry. 2018. PMID: 28910830 Free article. Review.
[Oxytocin and the mechanisms of alcohol dependence].
Faehrmann T, Zernig G, Mechtcheriakov S. Faehrmann T, et al. Among authors: zernig g. Neuropsychiatr. 2018 Mar;32(1):1-8. doi: 10.1007/s40211-017-0229-y. Epub 2017 Jun 21. Neuropsychiatr. 2018. PMID: 28639210 Review. German.
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Schoretsanitis G, et al. Among authors: zernig g. Ther Drug Monit. 2021 Feb 1;43(1):79-102. doi: 10.1097/FTD.0000000000000830. Ther Drug Monit. 2021. PMID: 33196621 Review.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Gründer G, Haen E, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Unterecker S, Waschgler R, Zernig G, Zurek G, Baumann P. Hiemke C, et al. Among authors: zernig g. Pharmacopsychiatry. 2018 Jan;51(1-02):e1. doi: 10.1055/s-0037-1600991. Epub 2018 Feb 1. Pharmacopsychiatry. 2018. PMID: 29390205 No abstract available.
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.
Wesner K, Hiemke C, Bergemann N, Egberts KM, Fekete S, Gerlach M, Havemann-Reinecke U, Lense XM, Riemer TG, Schoretsanitis G, Uhr M, Zernig G, Gründer G, Hart XM. Wesner K, et al. Among authors: zernig g. J Clin Psychiatry. 2023 Jul 19;84(5):22r14626. doi: 10.4088/JCP.22r14626. J Clin Psychiatry. 2023. PMID: 37471567
Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy.
Eichentopf L, Hiemke C, Conca A, Engelmann J, Gerlach M, Havemann-Reinecke U, Hefner G, Florio V, Kuzin M, Lieb K, Reis M, Riemer TG, Serretti A, Schoretsanitis G, Zernig G, Gründer G, Hart XM. Eichentopf L, et al. Among authors: zernig g. Front Psychiatry. 2022 Oct 17;13:972141. doi: 10.3389/fpsyt.2022.972141. eCollection 2022. Front Psychiatry. 2022. PMID: 36325531 Free PMC article.
Extremely High-Dosage Zolpidem Poisoning With Favorable Outcome.
De Donatis D, Porcelli S, Serretti A, Gaspari D, Caltagirone SS, Giupponi G, Ferraro M, Conca A, Florio V, Zernig G, Mercolini L. De Donatis D, et al. Among authors: zernig g. J Clin Psychopharmacol. 2021 Mar-Apr 01;41(2):222-223. doi: 10.1097/JCP.0000000000001353. J Clin Psychopharmacol. 2021. PMID: 33587390 No abstract available.
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C. Schoretsanitis G, et al. Among authors: zernig g. World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi: 10.1080/15622975.2018.1439595. Epub 2018 Mar 1. World J Biol Psychiatry. 2018. PMID: 29493375 Review.
135 results